Published in Med Care on April 01, 2016
Ultrasonography versus computed tomography for suspected nephrolithiasis. N Engl J Med (2014) 11.30
Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer. Arch Intern Med (2009) 10.27
Benefits and harms of CT screening for lung cancer: a systematic review. JAMA (2012) 8.71
Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med (2003) 7.73
The use of computed tomography in pediatrics and the associated radiation exposure and estimated cancer risk. JAMA Pediatr (2013) 6.18
Comparing yoga, exercise, and a self-care book for chronic low back pain: a randomized, controlled trial. Ann Intern Med (2005) 5.11
Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population. J Natl Cancer Inst (2007) 5.08
Association between obesity and psychiatric disorders in the US adult population. Arch Gen Psychiatry (2006) 5.06
Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model. Ann Intern Med (2008) 4.81
Use of diagnostic imaging studies and associated radiation exposure for patients enrolled in large integrated health care systems, 1996-2010. JAMA (2012) 4.71
Comparison of screening mammography in the United States and the United kingdom. JAMA (2003) 4.53
Comparative effectiveness of digital versus film-screen mammography in community practice in the United States: a cohort study. Ann Intern Med (2011) 4.31
Rising use of diagnostic medical imaging in a large integrated health system. Health Aff (Millwood) (2008) 4.05
Does utilization of screening mammography explain racial and ethnic differences in breast cancer? Ann Intern Med (2006) 3.95
Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study. Ann Intern Med (2011) 3.83
Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts. Ann Intern Med (2014) 3.46
Performance benchmarks for diagnostic mammography. Radiology (2005) 3.40
Factors associated with mammography utilization: a systematic quantitative review of the literature. J Womens Health (Larchmt) (2008) 3.02
Variability in interpretive performance at screening mammography and radiologists' characteristics associated with accuracy. Radiology (2009) 2.88
Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis. Ann Intern Med (2012) 2.85
Longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk. J Natl Cancer Inst (2007) 2.75
Physician predictors of mammographic accuracy. J Natl Cancer Inst (2005) 2.72
Screening mammograms by community radiologists: variability in false-positive rates. J Natl Cancer Inst (2002) 2.71
Chronic spinal pain and physical-mental comorbidity in the United States: results from the national comorbidity survey replication. Pain (2005) 2.50
Identifying women with dense breasts at high risk for interval cancer: a cohort study. Ann Intern Med (2015) 2.46
Prevention of breast cancer in postmenopausal women: approaches to estimating and reducing risk. J Natl Cancer Inst (2009) 2.35
Hormone therapy prescribing patterns in the United States. Obstet Gynecol (2004) 2.29
Racial and ethnic differences in breast cancer survival: how much is explained by screening, tumor severity, biology, treatment, comorbidities, and demographics? Cancer (2008) 2.23
Evaluation of abnormal mammography results and palpable breast abnormalities. Ann Intern Med (2003) 2.20
Dacarbazine causes transcriptional up-regulation of interleukin 8 and vascular endothelial growth factor in melanoma cells: a possible escape mechanism from chemotherapy. Mol Cancer Ther (2003) 2.08
Identifying minimally acceptable interpretive performance criteria for screening mammography. Radiology (2010) 2.06
Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population. J Clin Oncol (2003) 2.02
Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: a comparative modeling study of risk. Ann Intern Med (2012) 1.99
Fully humanized neutralizing antibodies to interleukin-8 (ABX-IL8) inhibit angiogenesis, tumor growth, and metastasis of human melanoma. Am J Pathol (2002) 1.96
Radiologist characteristics associated with interpretive performance of diagnostic mammography. J Natl Cancer Inst (2007) 1.95
Mammographic breast density and family history of breast cancer. J Natl Cancer Inst (2003) 1.95
Breast cancer risk by breast density, menopause, and postmenopausal hormone therapy use. J Clin Oncol (2010) 1.94
Modelling the cumulative risk of a false-positive screening test. Stat Methods Med Res (2010) 1.87
Screening outcomes in older US women undergoing multiple mammograms in community practice: does interval, age, or comorbidity score affect tumor characteristics or false positive rates? J Natl Cancer Inst (2013) 1.81
Influence of annual interpretive volume on screening mammography performance in the United States. Radiology (2011) 1.81
Longitudinal risk of herpes simplex virus (HSV) type 1, HSV type 2, and cytomegalovirus infections among young adolescent girls. Clin Infect Dis (2004) 1.79
Mammographic density and estrogen receptor status of breast cancer. Cancer Epidemiol Biomarkers Prev (2004) 1.78
Biennial versus annual mammography and the risk of late-stage breast cancer. J Natl Cancer Inst (2004) 1.76
Breast cancer yield for screening mammographic examinations with recommendation for short-interval follow-up. Radiology (2005) 1.75
Bias associated with self-report of prior screening mammography. Cancer Epidemiol Biomarkers Prev (2009) 1.75
Breast cancer detection rate: designing imaging trials to demonstrate improvements. Radiology (2007) 1.73
Inactivation of Brca2 promotes Trp53-associated but inhibits KrasG12D-dependent pancreatic cancer development in mice. Gastroenterology (2011) 1.70
Serum estradiol levels are not associated with urinary incontinence in midlife women transitioning through menopause. Menopause (2011) 1.53
Self-detection remains a key method of breast cancer detection for U.S. women. J Womens Health (Larchmt) (2011) 1.53
Physician workload in mammography. AJR Am J Roentgenol (2008) 1.53
Screening mammography in the American elderly. Am J Prev Med (2006) 1.52
Comparing the performance of mammography screening in the USA and the UK. J Med Screen (2005) 1.52
Serum IgE, tumor epidermal growth factor receptor expression, and inherited polymorphisms associated with glioma survival. Cancer Res (2006) 1.52
A semiparametric censoring bias model for estimating the cumulative risk of a false-positive screening test under dependent censoring. Biometrics (2013) 1.52
Modeling the dissemination of mammography in the United States. Cancer Causes Control (2005) 1.52
Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy. JAMA Intern Med (2013) 1.51
Adverse obstetric events are associated with significant risk of cerebral palsy. Am J Obstet Gynecol (2010) 1.50
Short-interval follow-up mammography: are we doing the right thing? J Natl Cancer Inst (2003) 1.49
A trial of an activating intervention for chronic back pain in primary care and physical therapy settings. Pain (2005) 1.49
Recommendation for short-interval follow-up examinations after a probably benign assessment: is clinical practice consistent with BI-RADS guidance? AJR Am J Roentgenol (2010) 1.49
Risk factors for inflammatory breast cancer and other invasive breast cancers. J Natl Cancer Inst (2013) 1.48
Statin use and prostate cancer risk in a large population-based setting. Cancer Causes Control (2008) 1.47
Disclosing harmful mammography errors to patients. Radiology (2009) 1.45
Airport full-body screening: what is the risk? Arch Intern Med (2011) 1.45
Molecular features of adult glioma associated with patient race/ethnicity, age, and a polymorphism in O6-methylguanine-DNA-methyltransferase. Cancer Epidemiol Biomarkers Prev (2005) 1.44
Prostate cancer: prediction of biochemical failure after external-beam radiation therapy--Kattan nomogram and endorectal MR imaging estimation of tumor volume. Radiology (2011) 1.44
Determinants of fluoroscopy time for invasive coronary angiography and percutaneous coronary intervention: insights from the NCDR(®). Catheter Cardiovasc Interv (2013) 1.43
Stability and predictors of health-related quality of life of inner-city girls. J Dev Behav Pediatr (2003) 1.41
Evidence-based target recall rates for screening mammography. Radiology (2007) 1.39
Screening mammography use among current, former, and never hormone therapy users may not explain recent declines in breast cancer incidence. Cancer Epidemiol Biomarkers Prev (2012) 1.39
Defining menopausal status in epidemiologic studies: A comparison of multiple approaches and their effects on breast cancer rates. Maturitas (2010) 1.38
Myocardial perfusion scans: projected population cancer risks from current levels of use in the United States. Circulation (2010) 1.38
Oral health-related quality of life in Germany. Eur J Oral Sci (2003) 1.38
Measurement of breast density with dual X-ray absorptiometry: feasibility. Radiology (2002) 1.38
Randomized trial of therapeutic massage for chronic neck pain. Clin J Pain (2009) 1.37
Distinguishing screening from diagnostic mammograms using Medicare claims data. Med Care (2014) 1.37
Differences in the quality of breast cancer care among vulnerable populations. Cancer (2005) 1.36
Evidence of poorer survival in pregnancy-associated breast cancer. Obstet Gynecol (2008) 1.36
Obesity, mammography use and accuracy, and advanced breast cancer risk. J Natl Cancer Inst (2008) 1.35
Reduced immunoglobulin E and allergy among adults with glioma compared with controls. Cancer Res (2004) 1.34
Comorbidities and mammography use interact to explain racial/ethnic disparities in breast cancer stage at diagnosis. Cancer (2011) 1.33
A prognostic approach to defining chronic pain. Pain (2005) 1.33
Statin use and breast cancer risk in a large population-based setting. Cancer Epidemiol Biomarkers Prev (2007) 1.31
Demographic factors, denture status and oral health-related quality of life. Community Dent Oral Epidemiol (2004) 1.31
Adverse events after screening and follow-up colonoscopy. Cancer Causes Control (2011) 1.27
Inhibition of platelet-derived growth factor-mediated proliferation of osteosarcoma cells by the novel tyrosine kinase inhibitor STI571. Clin Cancer Res (2002) 1.27
Racial, ethnic, and socioeconomic disparities in the prevalence of cerebral palsy. Pediatrics (2011) 1.26
Short-term outcomes of screening mammography using computer-aided detection: a population-based study of medicare enrollees. Ann Intern Med (2013) 1.26
Maternal and neonatal outcomes of assaults during pregnancy. Obstet Gynecol (2005) 1.25
Nonsynonymous coding single-nucleotide polymorphisms spanning the genome in relation to glioblastoma survival and age at diagnosis. Clin Cancer Res (2007) 1.23
Allergy-related polymorphisms influence glioma status and serum IgE levels. Cancer Epidemiol Biomarkers Prev (2007) 1.22
German short forms of the Oral Health Impact Profile. Community Dent Oral Epidemiol (2006) 1.19
ERCC1 and ERCC2 polymorphisms and adult glioma. Neuro Oncol (2005) 1.19
Risk factors for breast cancer in a population with high incidence rates. Breast Cancer Res (2003) 1.19
Reproducibility of BI-RADS breast density measures among community radiologists: a prospective cohort study. Breast J (2012) 1.18
Widespread pain as a risk factor for dysfunctional temporomandibular disorder pain. Pain (2003) 1.18
Management of asymptomatic ovarian and other adnexal cysts imaged at US: Society of Radiologists in Ultrasound Consensus Conference Statement. Radiology (2010) 1.18